Recall: The FDA did NOT Send Recently A Warning Letter To DoTerra And Young Living

 

Yesterday one of our editors posted the news both DoTerra as Young Living Essential Oils had received a FDA warning letter.

Both companies have indeed received such a letter however one year ago, in september 2014. Our editor did not check the source. We apologize for this outdated information.

Both companies have worked well with their compliance teams, and have received no further warnings from the FDA.

The Food and Drug Administration (FDA or USFDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments. The FDA is responsible for protecting and promoting public health.

The Warning Letter is the FDA's principal means of notifying regulated industry of violations and achieving prompt voluntary correction.

The United States Food and Drug Administration (FDA) defines a Warning Letter as

A correspondence that notifies regulated industry about violations that FDA has documented during its inspections or investigations.

Typically, a Warning Letter notifies a responsible individual or firm that the Agency considers one or more products, practices, processes, or other activities to be in violation of the Federal Food, Drug, and Cosmetic Act (the Act), its implementing regulations and other federal statutes.

Warning Letters should only be issued for violations of regulatory significance, i.e., those that may actually lead to an enforcement action if the documented violations are not promptly and adequately corrected. A Warning Letter is one of the Agency’s principal means of achieving prompt voluntary compliance with the Act.